The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 20, 2024

Filed:

Oct. 09, 2019
Applicant:

Astellas Pharma Inc., Tokyo, JP;

Inventors:

Jumpei Suemitsu, Tokyo, JP;

Megumi Ikeda, Tokyo, JP;

Moe Kohno, Tokyo, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/30 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01); A61K 51/04 (2006.01); A61K 51/10 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3007 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 51/0446 (2013.01); A61K 51/1051 (2013.01); A61K 51/1093 (2013.01); C07K 16/3092 (2013.01); C07K 2317/55 (2013.01); C07K 2317/71 (2013.01);
Abstract

Provided is a stable pharmaceutical composition comprising a labeling moiety-anti-human antibody Fab fragment conjugate, and the like. In the pharmaceutical composition comprising a labeling moiety-anti-human antibody Fab fragment conjugate, citric acid, phosphoric acid, 2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid or trishydroxymethyl aminomethane is added as a buffering agent, sucrose or glycerin is added as a stabilizer, a nonionic surfactant is added, and the pH is adjusted to 6.5 to 7.5. This enables suppression of generation of multimers and insoluble subvisible particles during preservation of the labeling moiety-anti-human antibody Fab fragment conjugate.


Find Patent Forward Citations

Loading…